Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,Inverse variance weighted,9,1.49 [1.15-1.93],0.0025992836177299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.23 [1.06-1.42],0.0050067281213394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.23 [1.07-1.40],0.0024794802968883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.63 [0.47-0.85],0.0027996107162359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.71 [0.55-0.91],0.008310027689937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,Inverse variance weighted,15,0.75 [0.63-0.90],0.0016583037432424
